BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2018
View Archived Issues
CARD-carrying AML killer
Read More
Cytokine gene therapy improves spinal cord regeneration
Read More
Metabolic differences of ApoE variants
Read More
APTO-253 is able to induce DNA damage in AML cells and can exploit BRCA1/2 recombination deficiency
Read More
Kelch-like family member 7: role in breast cancer progression and utility as prognostic marker
Read More
Rare, common genetic variants contribute to preterm birth
Read More
Landos Biopharma initiates phase I study of BT-11
Read More
CytoDyn to evaluate PRO-140 in cancer and immunological indications
Read More
ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing
Read More
Novel zebrafish models of Cantu syndrome using CrispR/Cas9-based nucleotide editing
Read More
Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging
Read More
FDA lifts clinical hold on phase I/II combination study of axalimogene filolisbac plus durvalumab
Read More
Janssen patents OGA inhibitors
Read More
Idenix and Merck & Co. disclose anti-HIV-1 compounds
Read More
OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors
Read More
University of Nebraska identifies NF-kappaB activation inhibitors
Read More
GlaxoSmithKline presents NRF2 activators
Read More
Atossa Genetics initiates phase II study of endoxifen in neoadjuvant breast cancer
Read More
FDA approves first drug to treat smallpox
Read More
Researchers find a relationship between prediabetes and overactive bladder
Read More
FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer
Read More
RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome
Read More
BGI-Shenzhen synthesizes new cancer vaccines
Read More
First-in-human study explores use of BAY-2287411 in mesothelin-expressing tumors
Read More
Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome
Read More
MaxCyte's cleared to begin clinical study of CAR therapy MCY-M11
Read More